Author:
Piccart Martine J.,Bernard-Many Chantal,Cardoso Fatima
Reference30 articles.
1. Second and subsequent lines of chemotherapy for metastatic breast cancer: What did we learn in the last two decades?;Cardoso;Ann Oncol,2002
2. Use of chemotherapy plus a monoclonal antibody against HER-2 for metastatic breast cancer that overexpresses HER-2;Slamon;N Engl J Med,2001
3. Epirubicin, alone or in combination chemotherapy, for metastatic breast cancer. Provincial Breast Cancer Disease Site Group and the Provincial Systemic Treatment Disease Site Group;Findlay;Cancer Prev Control,1998
4. A prospective randomized phase III trial comparing combination chemotherapy with cyclophosphamide, fluorouracil and either doxorubicin or epirubicin;J Clin Oncol,1988
5. A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients;J Clin Oncol,1991
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献